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Aiming to alter and/or improve permeation of active compounds in the skin, many strategies have 
been developed, including biophysical methods. One of the physical absorption techniques, currently 
known as Cryo Laser Phoresis (CLP), consists of an apparatus that emits radiation on polar or nonpolar 
molecules of the active substance, resulting in faster penetration when in comparison to the standard 
topical application. The goal of this work was to evaluate the efficacy of a method that proposes to 
increase cutaneous permeation of diclofenac sodium by using CLP technique. The influence on permeation 
was evaluated ex vivo, using Franz cell and human skin obtained from cosmetic surgery. The results 
were evaluated using statistical methods and data exploratory analysis: clusters, k-means and Principal 
Component Analysis. The results showed a larger increase in the concentration of diclofenac sodium in 
the dermis with the use of laser. In all samples (with or without laser application) it was observed that 
skin surface showed an amount of diclofenac sodium and that there was no active passage to the receptor 
liquid, suggesting that diclofenac sodium was not absorbed. These results indicate that CLP, when used 
under the conditions described in this study, is able to increase diclofenac sodium penetration and its 
retention into deeper layers.
Uniterms: Cryo Laser Phoresis/dematologic use. Cutaneous permeation. Diclofenac sodium/cutaneous 
permeation. Franz cell.
No sentido de alterar e/ou melhorar a penetração de substâncias na pele, diversas estratégias têm sido 
desenvolvidas, variando desde a aplicação de novos veículos e ativos encapsulados, até equipamentos 
que atuam por métodos biofísicos. Uma das técnicas de absorção física, atualmente conhecida como Crio 
Laser Forese (CLF), consiste em um aparato que emite radiação sobre moléculas polares ou apolares da 
substância ativa, tornando sua penetração mais rápida, se comparada à administração tópica comum. O 
objetivo deste trabalho foi avaliar a eficácia de um método que propõe aumentar a permeação cutânea 
do diclofenaco de sódio incorporado a um gel, por meio do uso da CLF. A influência sobre a permeação 
foi avaliada ex vivo, utilizando célula de Franz e pele humana obtida de cirurgia plástica. Os resultados 
foram balizados mediante aplicação de métodos estatísticos e análise exploratória de dados: clusters, 
k-means e Análise por Componentes Principais. Os resultados demonstraram aumento na concentração 
do diclofenaco de sódio na derme com o uso do laser. Em todas as amostras (com ou sem aplicação 
de laser), observou-se, uma quantidade de diclofenaco de sódio na superfície da pele e que não houve 
passagem de ativo para o líquido do receptor, sugerindo que o diclofenaco de sódio não foi absorvido. 
Estes resultados indicam que CLF usada sob as condições descritas neste estudo é capaz de aumentar a 
penetração do diclofenaco de sódio e sua retenção em camadas mais profundas da pele
Unitermos: Crio Laser Forese/uso em dermatologia. Permeação cutânea. Diclofenaco de sódio/permeação 
cutânea. Célula de Franz.
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INTRODUCTION
The skin has many functions and amongst them 
it is possible to emphasize its role as a barrier against 
exogenous agents, its utility to keep the homeostasis of 
the organism and to prevent internal water loss. Beyond 
that, it has been shown that it is an appropriate route for 
treatment systems, through transdermal administration 
of drugs (Leite-Silva et al., 2012). Several methods have 
been developed to increase the penetration of substances 
through skin. This includes the use of substances that 
act as permeation enhancers (chemical enhancers) 
in formulations or the development of new methods 
that modify the lipid and protein organization, inter 
and intracellular of the stratum corneum (biophysical 
enhancers) and can reversibly decrease the skin’s barrier 
property (Lopes et al., 2008; Silva et al., 2010).
Throughout the years there was a significant growth 
of knowledge in biochemical and metabolic processes 
involving substance flow through skin (Fluhr, Feingold, 
Elias, 2006). There are many factors that influence 
substance permeation through skin, such as formulation, 
particle size, component concentration, skin thickness, 
pH and sebum production, among others (Gallagher et 
al., 2003; Benson, 2005; Trommer, Neubert, 2006; Baroli, 
2010; Leite-Silva et al., 2012).
Several methods have been formulated to promote 
augmentation of transdermic transportation, having 
obtained varying levels of success. The promoting agents 
of chemical absorption can improve the skin’s permeability 
to small molecules, but also can lead to irritation of the 
surface of the skin or other factors that may limit their 
use. Iontophoresis uses electric fields to permeate ionized 
molecules through the skin using electrophoresis and 
electroosmosis for non-ionized molecules. This technique 
can be useful for applications that contain peptides and 
small proteins. Physical methods that temporarily improve 
skin permeability such as electroporation and ultrasound 
are used, representing perspectives in the application of 
drugs of low or high molecular weight (Patil, Saraogi, 
2014). However, not much studying has been done 
about the use of CryoLaser as a method of biophysical 
permeation.
In spite of the use of chemical permeation enhancers 
being widely studied, remarkable attention has been given 
to the benefits of biophysical permeation promoting 
techniques. One of them is known as Cryo Laser Phoresis 
(CLP), also named Cryopass Therapy, developed by 
C.I.R.C.E srl – Italy (Bonizzoni, 2007). It is applied with 
a device called Lasericemed, which emits a laser radiation 
on polar or nonpolar active substances and claims to make 
their absorption faster and more efficient when compared 
to the standard topical administration. The laser emission 
releases photons that collide with electrons of active 
substance molecules. This impact leads to photon energy 
transfer to electrons from more external orbitals, as kinetic 
energy form. This increases gravitational acceleration, 
allowing molecules to pass through skin and be delivered 
to the desired site (Terraneo et al., 2011).
The aim of this work was to evaluate the Cryo Laser 
Phoresis efficiency as biophysical method to promote 
diclofenac sodium cutaneous permeation. 
MATERIAL AND METHODS 
Material
Hydroxyethylce l lu lose  (CAS 9004-62-0 , 
Mapric Produtos Farmacosmeticos).The diclofenac 
sod ium work ing  s t anda rd  (monosod ium ac id 
2-[(2,6-dichlorophenyl) amino] benzene acetic salt) 
was donated by Medley Pharmaceutical Industry and 
methylchloroisothiazolinone and methylisothiazolinone 
were donated by Pro-ServQuimica LTDA. Acetonitrile 
(J. T. Baxter™) and methanol (J. T. Baxter™) were from 
HPLC gradeand phosphate buffer (PBS) components 
(NaCl - MW: 58,44; KCl - MW: 74,55; Na2HPO4 - MW: 
141,96 and KH2PO4 - MW: 136,09) were P. A. grade from 
Synth®. The tape stripping tapes (Standard S-Squame Disc 
CuDe 15109) were from CuDerm. The syringe filtersMilex 
were from Milipore®. The C18 chromatography column 
within 25 cm x 4.6 mm dimensions, 5 μm particle size 
was from ACE™.
Formulation
A gel was formulated using low irritant power and 
low cost raw materials (Table I). The gel was frozen until 
-20 ºC in suitable a package to attach to the device.
Permeation test
UNIFESP’s Ethics Committee previously approved 
the use of skin obtained by excision in cosmetic surgery, 
with protocol number 631972. After preparation, the skin 
was stored at a temperature of approximately -20 ºC.
The experiment was performed using dual 
compartment vertical diffusion cells (Franz cells) that 
were specifically modified and adapted exclusively for 
this experiment, with the superior portion suitable to 
receive a package that will be connected to the laser 
(Figure 1A). The skin was rehydrated for one hour with 
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phosphate buffer (PBS) pH 7.4. PBS was added to the 
receptor compartment and the system was immersed in a 
bath at 37 ºC, and stirred continuously for half an hour to 
stabilize the system. 
The bottle containing the active frozen gel was 
attached to the device and placed in contact with the skin 
for 10 min, with or without laser contact, in this case, 
employing the device Lasericemed turned on (Figure 1B). 
It is just an illustration, without the human skin and the 
receptor liquid only to demonstrate how the laser is used. 
This study was performed in triplicate.
The receptor liquid was collected at intervals of 10 
and 20 min. After 20 min, the gel applied to skin surface 
was removed with swabs™. Next, stratum corneum (SC) 
extraction was performed by “tape stripping” technique 
and the detachment of epidermis from dermis was 
performed (water at 60 ºC for 90 s). The samples were 
stored after being soaked in methanol for approximately 
15 min.
Afterwards, an aliquot from the supernatant liquid 
from each sample was removed and submitted to HPLC 
analysis. The final samples were: 10 min receptor liquid, 
20 min receptor liquid, swab, tapes 1-5, tapes 6-10, 
epidermis and dermis, with and without laser application.
Determination of diclofenac sodium in the 
samples
The methodology of diclofenac sodium analysis 
was developed based on conditions described on USP 35 
(2013) monograph and also on the methodology described 
by Klimes et al. (2001).
Considering these aspects, the chromatographic 
quantification of diclofenac sodium was performed by 
using HPLC degree solvents (acetonitrile and methanol) 
and C18 chromatography column within 25 cm x 4.6 mm 
dimensions, 5 μm particle size. Diclofenac sodium 
(working standard), with 99% purity was used as 
secondary standard. The analyses were performed in a 
liquid chromatograph model ACELLA 600, from Thermo 
Scientific™, equipped with quaternary pump system, 
column oven, automatic injector and diode array detector 
(DAD). Data was processed by ChromQuest™ software.
In addition, the following chromatography 
system parameters were also evaluated: retention 
factor, asymmetry (10%) and number of theoretical 
plates, according to (USP 35, 2013) recommended 
parameters.
In connection with the sample preparation, with 
0.5 mL fixed volume, all samples were previously filtered 
through 0.45 μm syringe filters and stored in 1.5 mL 
vials. The samples were diluted, when necessary, so 
active expected concentrations were coherent with the 
ones determined at calibration curve. Chromatography 
conditions for diclofenac sodium analysis were based on 
the US Pharmacopoeia (USP 35), with some modifications 
for optimizing the method, according to gel matrix and 
biological matrix content, assessing parameters as: 
stationary phase and chromatographic column dimensions, 
content, mobile phase flow, temperature, injection volume, 
sample solution and standard solution concentration 
related to HPLC equipment response. 
After optimization, an isocratic method was 
established with mobile phase composed of 30% phosphate 
buffer (pH 2.5) and 70% acetonitrile, with 1.0 mL.min-1 
flow, using C18 column with 25 cm x 4.6 mm, 5 μm 
particle size and DAD detector monitoring 254 nm 
TABLE I - Composition of formulations (%, w/w) evaluated
Ingredient F1 F2 F3
Hydroxyethylcellulose 0.6 0.6 0.6
Methylchloroisothiazolinone (and) Methylisothiazolinone 0.1 0.1 0.1
Diclofenac Sodium 1.0 1.5 2.0
Water 98.3 97.8 97.3
FIGURE 1 - (A) Adapted Franz cell and the package where 
the gel was frozen; (B) Simulation of the laser attached to the 
package that contains diclofenac sodium frozen gel. 
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wavelength. The injected volume of each sample was 
25 μL and 9 min run time.
A stock solution was prepared in a volumetric flask, 
transferring 12.5 mg of diclofenac sodium in 25 mL of 
methanol, obtaining a 500 μg.mL-1 solution. From the 
stock solution and using 10 mL volumetric flasks, dilutions 
were prepared leading to the concentrations: 2.5; 5.0; 12.5; 
25; 50; 100 and 150 µg.mL-1 in methanol. The standard 
concentrations for the calibration curve were prepared 
in triplicate and analyzed in the previously described 
chromatography conditions.
Statistical analysis
At the data exploratory phase, t Student test was 
applied, which allowed verifying significant differences 
between “With Laser” and “Without Laser” situations, to 
the Dermis (D). Given the hypothesis absence, a priori, to 
all other results, cluster analysis method application was 
chosen (p-value < 0.05 was considered to be statistically 
significant).
RESULTS AND DISCUSSION
Diclofenac sodium was chosen as a marker due to 
its hydrophilic characteristics that hinder its flow through 
the skin’s lipid layer (Lopes et al., 2008) and because it 
can be a good alternative for challenging the biophysical 
enhancer. Gaur et al. (2014) had studied the transdermal 
formulations containing permeation enhancers that cause 
skin damage and diclofenac was used as a model drug. 
The presence of ceramid specifically promotes drug 
permeation through SC and dermis and also contributes 
to stability and non-irritancy.
Escribano et al. (2003) evaluated the transdermal 
permeation of sodium diclofenac. Permeation studies were 
carried out in vitro using human skin from plastic surgery 
as a membrane – as we did in our research. However, they 
used chemical enhancers instead of biophysical methods 
to improved diclofenac permeation. 
The influence of an erbium:YAG laser on the 
transdermal delivery of drugs across skin was studied 
in vitro by Lee et al. (2001). The researchers concluded 
that the use of an erbium:YAG laser is a good method for 
enhancing transdermal absorption of both lipophilic and 
hydrophilic drugs, because it allows precise control of SC 
removal, and this ablation of SC can be reversible to its 
original normal status. Nevertheless, the laser used in this 
work does not have ablation potential. 
The Figure 2 shows the comparative performance of 
samples submitted to the laser treatment and not submitted 
to the laser treatment; highlighted are the Swab and dermis 
samples, in gray are the other samples with inexpressive 
graphic representation. 
The statistical analysis reinforces the validity of 
these data. The Figure 3 shows a hierarchical grouping 
analysis dendrogram (K-means) that allowed verifying 
the evident dissimilarity of results obtained from the swab 
(with and without laser and dermis (with laser)), when 
compared to the other experimental data.
Complementarily to cluster analysis, data was 
treated by Principal Component Analyses (PCA) method 
application, permitting the gathering of similar behavior 
data groups (Figure 4). It basically consists of the 
diagonalization of a symmetric data matrix, resulting in 
a new group of variables (principal components), which 
are linear combinations of the original variables and non-
correlated. In this way, a new space is generated in which 
the variables can be projected and classified into categories 
or groups. The application of this method allowed the 
clear differentiation (grouping) between the variables to 
be verified, highlighting the swab and the dermis (Figure 
4A), confirming that the laser treatment promotes results 
on dermis that show singular behavior when compared 
FIGURE 2 - Comparative performance of samples submitted to 
the laser treatment and not submitted to laser treatment. Notes: 
SL = Swab with laser; S = Swab without laser; E1L = tape strip 
1 to 5 with laser; E1 = tape strip 1 to 5 without laser; E2L = tape 
strip 6 to 10 with laser; E2 = tape strip 6 to 10 without laser; E3L 
= tape strip 11 to 15 with laser; E3 = tape strip 11 to 15 without 
laser; E4L = tape strip 16 to 20 with laser; E4 = tape strip 16 
to 20 without laser; EPL= epidermis with laser; EP= epidermis 
without laser; DL= Dermis with laser; D= Dermis without laser; 
L10L= receptor liquid 10 min with laser; L10= receptor liquid 
10 min without laser, L20L= receptor liquid 20 min with laser; 
L20= receptor liquid 20 min without laser.
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to the other result groups. Figure 4B highlights the 
differentiation of dermis with laser (DCL) and Swab with 
and without laser (SCL and SSL), compared to the results 
set considering all tested concentrations. 
According Yilmaz and Ciltas (2015), diverse 
methodologies are described in the literature to diclofenac 
qualitative and quantitative analysis, using many analytical 
techniques. However, most of them use high performance 
liquid chromatography with ultraviolet detection (HPLC-
UV) (Arcelloni et al., 2001; Bhattacharya et al., 2013). 
Therefore, this work methodology was developed based 
on conditions of analysis described on USP 35 (2013) 
monograph and on the methodology described by Klimes 
et al. (2001). 
The method presented suitable specificity as 
it considered the excipients used in the gel vehicle. 
Representative chromatograms from samples with or 
without diclofenac sodium are shown on Figure 5.
The analytical curve, based on the expected active 
concentrations on the different skin layers, presented 
results and Coefficient of Variation (CV) suitable with 
the aim of the analysis. These analyses were performed in 
triplicate and their results are shown in Table II.
The obtained coefficient of determination was 
0.9966, which shows good explaining ability and linearity 
coefficient of variation of 4.7% from Detection Limit (DL), 
determined in 3.3 μg.mL-1 until maximum concentration 
established in calibration (50 μg.mL-1).
The chromatographic system evaluation parameter 
values to analyze the standards were: retention factor = 
4.2, asymmetry (10%) = 1.16, number of theoretical plates 
= 15582, indicating chromatographic system adequacy 
FIGURE 3 - Cluster Analysis about differentiation of dermis with 
laser and Swab with and without laser when compared to the 
other experimental data. Notes: SCL = Swab with laser; SSL= 
Swab without laser; E1CL = tape strip 1 to 5 with laser; E1SL 
= tape strip 1 to 5 without laser; E2CL = tape strip 6 to 10 with 
laser; E2SL = tape strip 6 to 10 without laser; E3CL = tape strip 
11 to 15 with laser; E3SL = tape strip 11 to 15 without laser; 
E4CL = tape strip 16 to 20 with laser; E4SL = tape strip 16 to 20 
without laser; EPCL= epidermis with laser; EPSL= epidermis 
without laser; DCL= Dermis with laser; DSL= Dermis without 
laser; L10CL= receptor liquid 10 min with laser; L10SL= 
receptor liquid 10 min without laser, L20CL= receptor liquid 
20 min with laser; L20SL= receptor liquid 20 min without laser.
FIGURE 4 - Principal Component Analysis method application, allowing the gathering of similar behavior data groups. (A) 
Differentiation of variables swab and dermis when submitted to laser treatment, (B) differentiation of dermis with laser (DCL) and 
swab with and without laser (SCL and SSL) compared to the results set considering all tested concentrations.
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and compatibility with the USP 35 (2013) recommended 
parameters. The values of all evaluation parameters to the 
standards are on Table III.
These results of performance parameters, including 
specificity, range, linearity, precision (CV), LOD (limit of 
detection) and LOQ (limit of quantification), presented by 
the HPLC method used for the determination of diclofenac 
sodium in the samples obtained from the permeation tests, 
assure the sensibility and confidence necessary for the 
assessment of the data connected with the potential of the 
TABLE II - Results obtained from diclofenac sodium solution analysis to build an analytical curve
Concentration (mg.mL-1) Area 1 Area 2 Area 3 Mean ± SD CV (%)
0.0025 564670 564970 558828 562823 ± 3463 0.6
0.005 734929 742080 737941 738317 ± 2831 0.4
0.0125 2042415 2043344 2053681 2046480 ± 5106 0.25
0.025 3781948 3794774 3786593 3787772 ± 5302 0.14
0.05 7237005 7245341 7855082 7445809 ± 289419 0.4
Notes: CV = Coefficient of Variation. SD = Standard Deviations
FIGURE 5 - Chromatogram analysis obtained from samples without diclofenac sodium addition (A) and samples with diclofenac 
sodium (B). Chromatographic conditions: chromatographic column ACE® C18 (25 cm x 4.6 mm, 5 μm particle size), mobile phase 
containing 30% phosphate buffer (pH 2,5) and 70% acetonitrile, 1.0 mL.min-1 flow, 254 nm detection, 25 μL injected volume and 
analysis time 9 min.
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CLP to increase the cutaneous permeation of diclofenac 
sodium.
The performed analysis, in all three investigated 
concentrations (1.0%, 1.5%, 2.0%) presented the same 
behavior, as shown on Figure 2. All showed a higher 
increase of the substance in the dermis with the laser use, 
suggesting that laser employment in these conditions 
increases diclofenac sodium penetration and its retention 
into deeper layers. In all samples (with or without laser 
application), it is observed that skin surface (swab) 
showed, as expected, a much higher diclofenac sodium 
quantity (out of method work range) and that there is 
no active passage to the receptor liquid, suggesting that 
diclofenac sodium is not absorbed.
Using an intermediate concentration as a numeric 
example, it is possible to verify that without laser 
employment, the analysis representing the first 5 layers 
from stratum corneum (0.049 mg.mL-1), layers 6 to 10 
(0.014 mg.mL-1), layers 11 to 15 (0.008 mg.mL-1) and 
layers 16 to 20 (0.004 mg.mL-1) show that the found 
diclofenac sodium quantity decreases according to the 
analyzed stratum corneum depth, remaining low in 
dermis (0.011 mg.mL-1). As in the samples that underwent 
laser treatment, the samples that represent the first 5 
stratum corneum layers (0.024 mg.mL-1), layers 6 to 10 
(0.011 mg.mL-1), layers 11 to 15 (0.006 mg.mL-1) and 
layers 16 to 20 (0.004 mg.mL-1) also presented as a result 
a decrease in concentrations according to the analyzed 
stratum corneum depth and a significant increase in the 
dermis (0.117 mg.mL-1).
 New studies must be conducted with distinct 
physicochemical properties molecules, aiming to measure 
the permeation enhancer capacity on different situations. 
Finally it must be highlighted that, because of operational 
limitations, this experiment was adapted to evaluate only 
the effects of laser application on a frozen active solution 
in a hydrophilic gel, when applied over the skin. According 
to Bonizzoni (2007), after applying the gel with the laser, 
skin surface should be exposed to a light beam again by 
a scanning device, which could have contributed to the 
permeation process if it had been used in this experiment.
CONCLUSION
The results indicate that the Cryo Laser Phoresis 
technique, when used under the conditions described in 
this study, is able to enhance skin permeation of diclofenac 
sodium and potentially of other molecules with similar 
physical-chemical proprieties, thus constituting an 
interesting alternative to drug administration, especially 
in situations in which penetration in deeper skin layer is 
necessary and where the systemic use may be unfeasible 
or may be capable to promote unpleasant reactions.
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